IGF-1 LR3 (Injectable) in Wyoming
Doctor-prescribed IGF-1 LR3 (Injectable) for Wyoming residents. Reviewed by licensed Wyoming physicians, compounded at FDA-registered pharmacies, and shipped to your door.
All-in monthly price
No membership fee · this is the full price · free shipping · avg 4-week supply
Add in-depth bloodwork
Optional — add a physician-reviewed at-home blood panel to your plan.
Your sex-hormone baseline plus the safety markers that matter on therapy — blood counts, liver and kidney function — from one painless upper-arm device. Matched to your sex (PSA for men; progesterone & FSH for women). No needle, no clinic, physician-reviewed.
This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.
Reviewed by Dr. Gene, MD · Board-certified Family Medicine
Every Pepti prescription is reviewed by a licensed U.S. physician before it's dispensed — and only provided if clinically appropriate.
How it works in Wyoming
- 1Complete a free online intake (~5 minutes).
- 2A licensed Wyoming physician reviews your case within 24 hours.
- 3Your prescription ships from our FDA-registered compounding pharmacy.
- 4Free shipping arrives 2–4 business days later. Refills ship automatically when your supply runs out — cancel anytime.
What IGF-1 LR3 (Injectable) does
IGF-1 LR3 is a modified version of Insulin-like Growth Factor 1 with a longer half-life. It is prescribed only after a physician reviews your intake and labs, and is not appropriate for every patient.
Amounts shown are per unit. Compounded fresh at a US FDA-registered pharmacy.
Quality
Every batch independently tested
Every medication batch dispensed through Pepti is independently tested by a qualified third-party laboratory for applicable quality and safety standards before the pharmacy releases it. Batches are tested to the same standard used by 503B outsourcing facilities.
Sterility
USP <71>Confirms the finished preparation is free of viable microorganisms.
Bacterial endotoxins
USP <85>Screens for endotoxins that can cause fever or inflammatory reactions.
Potency
AssayVerifies the labeled concentration of the active peptide is what is in the vial.
Purity
HPLCChecks the active peptide against impurities and degradation products.
Identity
Mass spectrometryConfirms the peptide in the vial is the correct molecule.
pH
USP <791>Confirms the solution sits within the range specified for injection.
Particulate matter
USP <788>Checks the finished vial for visible and sub-visible particles.
Container closure integrity
USP <1207>Confirms the vial seal holds so sterility is maintained through the beyond-use date.
Recent lots
- Lot 100526-IGF-0.2
Tested 2026-10-07 · Biolink Life Sciences Carolinas
Sterility
Sterile
Endotoxin
<2 EU/mL
Potency
99.5%
- Lot 092826-IGF-0.2
Tested 2026-09-30 · Biolink Life Sciences Carolinas
Sterility
Sterile
Endotoxin
<2 EU/mL
Potency
99.3%
- Lot 092126-IGF-0.2
Tested 2026-09-23 · Biolink Life Sciences Carolinas
Sterility
Sterile
Endotoxin
<2 EU/mL
Potency
99.8%
Telemedicine in Wyoming.
Wyoming permits telemedicine prescribing under Wyoming Board of Medicine rules. A Wyoming-licensed physician can establish the patient relationship through online intake review for non-controlled medications. Pepti is available in all 50 states and Washington, D.C.
Wyoming's dispersed population makes telehealth a primary access path for specialty care.
Wyoming cities Pepti serves
Your protocol
How IGF-1 LR3 is prescribed in Wyoming.
Who it's for
- Adults whose physician is supporting muscle recovery and growth
- Experienced patients already comfortable with peptide protocols
Your physician decides whether IGF-1 LR3 is appropriate for you after reviewing your intake and labs.
Directions & duration
Inject 0.25 mL (25 units) subcutaneously Monday through Friday nights at bedtime.
What's included
- Licensed physician review of your intake, history, and labs
- Medication compounded to your prescription by a PCAB-accredited, FDA-registered pharmacy
- Every batch independently tested before release
- Sterile syringes and alcohol prep pads for injectables
- Tracked delivery to your door, refills on schedule
- Message your physician anytime; dose changes without an appointment
Storage & handling
- Store refrigerated (36–46°F / 2–8°C) at all times, including before first use.
- One vial is your monthly supply. A fresh vial ships to your Wyoming address every 28 days on your refill schedule, so you're always well inside the beyond-use date on your label.
- Protect from light. Wipe the stopper with an alcohol pad before every draw.
- Dispose of syringes in the sharps container per the included instructions.
What to expect
A typical course of IGF-1 LR3 in Wyoming.
The science
How IGF-1 LR3 works, and what the research shows.
How it works
IGF-1 LR3 is a modified insulin-like growth factor 1 with an arginine substitution and 13-amino-acid extension that sharply reduce binding to IGF-binding proteins — keeping more of the peptide free and active, with a substantially longer effective half-life than native IGF-1.
It signals through the IGF-1 receptor, the body's primary mediator of growth-hormone-driven tissue growth.
Clinical evidence
Native IGF-1 (mecasermin) is FDA-approved for severe primary IGF-1 deficiency, which anchors the receptor biology in approved human medicine.
The LR3 analog itself, however, has no human clinical trials — its anabolic data comes from laboratory and animal research, making it one of the more investigational peptides physicians prescribe.
References
- Philippou A, Maridaki M, Halapas A et al.. The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology · In Vivo (2007) · PMID 17354613
- Francis GL, Ross M, Ballard FJ et al.. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency · J Mol Endocrinol (1992) · PMID 1378742
- Tomas FM, Knowles SE, Owens PC et al.. Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats · Biochem J (1992) · PMID 1371669
- Read LC, Tomas FM, Howarth GS et al.. Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats · J Endocrinol (1992) · PMID 1613443
- Conlon MA, Tomas FM, Owens PC et al.. Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig · J Endocrinol (1995) · PMID 7561636
- Guler HP, Zapf J, Froesch ER. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults · N Engl J Med (1987) · PMID 3299085
- Chernausek SD, Backeljauw PF, Frane J et al.. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity · J Clin Endocrinol Metab (2007) · PMID 17192294
- Renehan AG, Zwahlen M, Minder C et al.. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis · Lancet (2004) · PMID 15110491
- Adams GR, McCue SA. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats · J Appl Physiol (1998) · PMID 9572822
- Musarò A, McCullagh K, Paul A et al.. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle · Nat Genet (2001) · PMID 11175789
- Barton-Davis ER, Shoturma DI, Musaro A et al.. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function · Proc Natl Acad Sci U S A (1998) · PMID 9861016
- Allard JB, Duan C. IGF-Binding Proteins: Why Do They Exist and Why Are There So Many? · Front Endocrinol (Lausanne) (2018) · PMID 29686648
- Kohler M, Thomas A, Walpurgis K et al.. Detection of His-tagged Long-R3-IGF-I in a black market product · Growth Horm IGF Res (2010) · PMID 20675162
- Knuppel A, Fensom GK, Watts EL et al.. Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank · Cancer Res (2020) · PMID 32709735
- Watts EL, Perez-Cornago A, Fensom GK et al.. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis · Int J Epidemiol (2023) · PMID 35726641
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
PCAB-accredited pharmacies on every order.
Every fulfillment runs through a PCAB-accredited pharmacy.
See the lab results
- Rigorous third-party quality & safety inspections
- Cleanliness and sterile processes
- Proper ingredient sourcing
- Accurate dosing and formulation
- Staff training and procedures
- Accredited by NABP & ACHC
Frequently asked
about IGF-1 LR3 (Injectable) in Wyoming.
Yes. IGF-1 LR3 (Injectable) is legal when prescribed by a physician licensed in Wyoming and dispensed by an FDA-registered compounding pharmacy. Wyoming permits telemedicine prescribing under Wyoming Board of Medicine rules. A Wyoming-licensed physician can establish the patient relationship through online intake review for non-controlled medications.
Most orders ship from our FDA-registered compounding pharmacy within 1–3 business days after physician approval. Delivery within Wyoming typically arrives 1-3 business days after shipment. Pepti serves patients across Wyoming including Cheyenne, Casper, Laramie, and Gillette.
No. Pepti operates as a fully telehealth platform in Wyoming. Wyoming permits telemedicine prescribing under Wyoming Board of Medicine rules. A Wyoming-licensed physician can establish the patient relationship through online intake review for non-controlled medications.
IGF-1 LR3 (Injectable) starts at $259 at Pepti. Pepti is subscription-based — your refill ships when your supply runs out, and you can cancel anytime. Pricing is the same nationwide — no Wyoming-specific markup. Shipping is free.
Yes — Pepti is available in all 50 states and Washington, D.C. Wherever you are in the country, a physician licensed in your state reviews your intake and your medication ships from an FDA-registered compounding pharmacy.
You don't need an in-person peptide clinic — Pepti provides doctor-prescribed IGF-1 LR3 (Injectable) entirely online anywhere in Wyoming. A physician licensed in Wyoming reviews your intake, and your medication ships from an FDA-registered compounding pharmacy to your door. Unlike "research use only" peptide sites, every Pepti order requires a valid patient-specific prescription and a licensed dispensing pharmacy.
No. "Research use only" IGF-1 LR3 (Injectable) is sold with no prescription, no physician, and no dispensing pharmacy, and is not legally sold for human use — independent testing of research-grade peptides has repeatedly found underdosing, mislabeling, and contamination. Prescription IGF-1 LR3 (Injectable) is compounded for you at an FDA-registered US pharmacy after a licensed physician's review. When comparing IGF-1 LR3 (Injectable) options in Wyoming, only consider providers that can name their prescribing physicians and their dispensing pharmacy.
32 more questions about Pepti, answered.Show fewer
Pepti serves all of Wyoming. A physician licensed in Wyoming reviews every order within 4 hours, the prescription is compounded by a state-licensed, FDA-registered pharmacy, and it ships free and tracked to any Wyoming street address. The price is the same as every other state.
Yes. The whole process is online in Wyoming: a free assessment, physician review, messaging, dose changes, and refills through your Pepti account or the Hello Pepti app. No clinic visit is required.
Pepti ships IGF-1 LR3 to Wyoming directly from the pharmacy: free, tracked, unbranded, in insulated packaging with ice packs for refrigerated medication. The pharmacy compounds in 1-3 business days and delivery takes 1-3 business days after shipment. PO Boxes are not accepted.
Every treatment on Pepti's catalog ships to Wyoming. Eligibility is confirmed during the assessment from your Wyoming shipping address, and if anything ever cannot ship to your address it is refunded.
The same as everywhere Pepti serves: one all-in monthly price per treatment that includes the medication, the physician, and shipping, with no Wyoming-specific markup and no membership or consult fee. Every price is on the product page.
Yes. Pepti's physicians hold licenses in Wyoming, and only a physician licensed where you live reviews and prescribes your order. Their names and credentials are on the providers page.
Yes. Pepti's partner pharmacies are state-licensed, FDA-registered 503A compounding pharmacies licensed to dispense into Wyoming, and every batch is independently tested before it ships.
IGF-1 LR3 is a modified version of Insulin-like Growth Factor 1 with a longer half-life. It is prescribed only after a physician reviews your intake and labs, and is not appropriate for every patient. IGF-1 LR3 is prescription-only at Pepti: a licensed physician reviews your assessment and, if appropriate, prescribes it to be compounded by a state-licensed, FDA-registered pharmacy.
IGF-1 LR3 is commonly prescribed for: Adults whose physician is supporting muscle recovery and growth; Experienced patients already comfortable with peptide protocols. Whether it is appropriate for you is decided by the reviewing physician from your history, medications, and labs where required.
Yes. IGF-1 LR3 is prescription-only. The free online assessment takes about five minutes, a physician licensed in Wyoming reviews it within 4 hours, and if approved the prescription goes to the pharmacy. If not approved, the medication charge is refunded.
No. IGF-1 LR3 can be prescribed from the assessment alone. Bloodwork is required only for the GLP-1s and growth-hormone secretagogues, and the intake tells you if a medication on your order needs it.
IGF-1 LR3 is a subcutaneous injection into the abdomen or thigh with a small insulin syringe. Your kit ships with sterile syringes and alcohol prep pads, and the exact dose and schedule are printed on the pharmacy label. Dosing videos are in your account.
One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.
Once per fill, $259 each time, when the next vial ships. It renews until you cancel, which you can do anytime from your account with no cancellation fee.
The compounded IGF-1 LR3 with sterile syringes and alcohol prep pads, free tracked shipping in an unbranded box with insulated packaging, the physician review, ongoing physician care and dose adjustments, and unlimited messaging.
Like any prescription medication, IGF-1 LR3 can have side effects, and the physician screens your history, current medications, and allergies for anything that would make it inappropriate before prescribing. The medication-specific consent lists the known risks, and you can message your physician about anything you notice. Seek emergency care for severe symptoms.
Response varies by person, goal, and dose, and IGF-1 LR3 is prescribed for ongoing use rather than a short trial. Your physician sets expectations at approval, tracks how you respond through your account, and adjusts the dose without an appointment.
Yes. Request it from your account or the app; your physician approves or declines. If approved you pay for the additional medication at the pharmacy's cost and the new dose applies to your next shipment.
Yes. Add IGF-1 LR3 to a plan with another treatment and both go through one assessment and one physician review, shipping together on one schedule. Each keeps its own catalog price. The physician reviews the combination and can adjust it.
No. Compounded IGF-1 LR3 is not FDA-approved. It is prepared to your physician's prescription by a state-licensed, FDA-registered 503A pharmacy and every batch is independently tested before release.
Yes, when prescribed by a licensed physician and dispensed by a licensed pharmacy, which is how Pepti provides it in Wyoming. Research-use-only IGF-1 LR3 sold without a prescription is labeled not for human use and is a different product.
IGF-1 LR3 is a modified insulin-like growth factor 1 with an arginine substitution and 13-amino-acid extension that sharply reduce binding to IGF-binding proteins — keeping more of the peptide free and active, with a substantially longer effective half-life than native IGF-1. At Pepti it is prescribed to support longer-acting igf-1 analog, supports recovery, physician-supervised, bloodwork-driven dosing. Individual response varies, and your physician sets expectations at approval.
IGF-1 LR3 is a modified insulin-like growth factor 1 with an arginine substitution and 13-amino-acid extension that sharply reduce binding to IGF-binding proteins — keeping more of the peptide free and active, with a substantially longer effective half-life than native IGF-1. It signals through the IGF-1 receptor, the body's primary mediator of growth-hormone-driven tissue growth. Compounded IGF-1 LR3 is not FDA-approved; it is prescribed off-label by a licensed physician after reviewing your assessment.
IGF-1 LR3 is prescribed for longer-acting igf-1 analog, supports recovery, physician-supervised, bloodwork-driven dosing. It is commonly requested by adults whose physician is supporting muscle recovery and growth; Experienced patients already comfortable with peptide protocols. Whether it is appropriate for you is the reviewing physician's decision.
IGF-1 LR3 is studied for longer-acting igf-1 analog, supports recovery, physician-supervised, bloodwork-driven dosing. Those are the goals it is prescribed to support at Pepti; results vary by person, dose, and consistency, and no outcome is guaranteed. Your physician tracks how you respond through your account.
Native IGF-1 (mecasermin) is FDA-approved for severe primary IGF-1 deficiency, which anchors the receptor biology in approved human medicine. The LR3 analog itself, however, has no human clinical trials — its anabolic data comes from laboratory and animal research, making it one of the more investigational peptides physicians prescribe. References are listed on this page.
At Pepti. Complete the free assessment, a physician licensed in Wyoming reviews it within 4 hours, and if appropriate IGF-1 LR3 is compounded by a state-licensed, FDA-registered pharmacy and shipped free to your door for $259 per month, all-in. Not prescribed means refunded.
Injectable vial: 5 mL at 0.2 mg/mL, containing 1 mg IGF-1 LR3. Injectable vial: 5 mL at 1 mg/mL, containing 5 mg IGF-1 LR3. One vial is your monthly supply at the prescribed dose, and a fresh one ships about every 28 days.
Not currently. IGF-1 LR3 ships as a multi-dose vial with sterile syringes and prep pads. The pepti Pen is available for 10 other treatments.
$259 per month covers the compounded IGF-1 LR3, the physician review, ongoing physician care including dose adjustments and refill review, unlimited messaging, and free tracked shipping. There is no membership, consult, visit, or refill fee; the only separate charges are optional at-home lab panels and a physician-approved dose increase billed at pharmacy cost.
Yes. IGF-1 LR3 is on Pepti's live catalog, which lists only treatments a partner pharmacy can compound and ship today. If a physician prescribes it, it ships; if it ever cannot be dispensed, the charge is refunded.
IGF-1 LR3 ships to 50 states, free and tracked, in insulated unbranded packaging. Eligibility is confirmed during the assessment from your shipping address.
IGF-1 LR3 (Injectable) in every state
Pepti is available in all 50 states and Washington, D.C.
Pepti operates in Wyoming through licensed physician partnerships. Compounded medications are produced at FDA-registered 503A pharmacies. Treatment decisions are made by your prescribing physician.